XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Assets:    
Cash and cash equivalents $ 9,098 $ 8,586
Investments 2,134 2,407
Accounts receivable, net 43,857 36,469
Inventories 18,962 18,107
Other current assets 3,058 3,076
Total current assets 77,109 68,645
Long-term investments 31,553 28,934
Property and equipment, net 12,838 12,993
Operating lease right-of-use assets 15,271 15,944
Goodwill 85,478 91,272
Intangible assets, net 25,984 27,323
Separate accounts assets 1,934 3,311
Other assets 5,160 4,793
Total assets 255,327 253,215
Liabilities:    
Accounts payable 17,764 15,892
Pharmacy claims and discounts payable 27,085 24,166
Health care costs payable 16,098 15,064
Accrued expenses and other current liabilities 23,415 20,810
Other insurance liabilities 1,096 1,183
Current portion of operating lease liabilities 1,909 1,751
Short-term debt 1,247 2,119
Current portion of long-term debt 4,081 3,624
Total current liabilities 92,695 84,609
Long-term operating lease liabilities 14,007 14,899
Long-term debt 60,508 60,527
Deferred income taxes 3,547 3,806
Separate accounts liabilities 1,934 3,311
Other long-term insurance liabilities 4,767 4,902
Other long-term liabilities 4,759 5,431
Total liabilities 182,217 177,485
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,786 shares issued and 1,270 shares outstanding at September 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus 50,181 49,661
Treasury stock, at cost: 516 and 518 shares at September 30, 2025 and December 31, 2024 (36,776) (36,818)
Retained earnings 59,107 62,837
Accumulated other comprehensive income (loss) 416 (120)
Total CVS Health shareholders’ equity 72,928 75,560
Noncontrolling interests 182 170
Total shareholders’ equity 73,110 75,730
Total liabilities and shareholders’ equity $ 255,327 $ 253,215